Asmaa A. Abo Elqasem

Dr. Asmaa A. Abo Elqasem

Faculty of Science, Al-Azhar University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Reham HammadReham Hammad
Reham Hammad
RAReda Aglan
Reda Aglan
SMShaymaa A. Mohammed
Shaymaa A. Mohammed
EAEman Abu-Elnasr Awad
Eman Abu-Elnasr Awad
MEMarwa A. Elsaid
Marwa A. Elsaid
Nadia M HamdyNadia M Hamdy
Nadia M Hamdy
Virus-related hepatocellular carcinoma (HCC) pathogenesis involves liver inflammation, therefore, despite successful treatment, hepatitis C virus (HCV) may progress to HCC from initiated liver cirrhosis. Cytotoxic T cells (Tcs) are known to be involved in HCV-related cirrhotic complications and HCC pathogenesis. The inhibitory checkpoint leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is expressed on Tcs. Therefore, we aimed to determine whether the Tc expression level of LAIR-1 is associated with HCC progression and to evaluate LAIR-1 expression as a noninvasive biomarker for HCC progression in the context of liver cirrhosis related to HCV genotype 4 (G4) in Egyptian patients’ peripheral venous blood liquid biopsy. A total of 64 patients with HCC and 37 patients with liver cirrhosis were enrolled in this case-controlled study, and their LAIR-1 expression on Tc related to the progression of liver cirrhosis was examined and compared to that of the apparently healthy control group (n = 20). LAIR-1 expression was analyzed using flow cytometry. Results: The HCC group had significantly higher LAIR-1 expression on Tc and percentage of Tc positive for LAIR-1 (LAIR-1+Tc%) than the HCV G4-related liver cirrhosis group. LAIR-1+Tc% was correlated with the HCC surrogate tumor marker AFP (r = 0.367, p = 0.001) and insulin resistance and inflammation prognostic ratios/indices. A receiver operating characteristic (ROC) curve revealed that adding LAIR-1+Tc% to AFP can distinguish HCC transformation in the Egyptian patients’ cohort. Upregulated LAIR-1 expression on Tc could be a potential screening noninvasive molecular marker for chronic inflammatory HCV G4 related liver cirrhosis. Moreover, LAIR-1 expression on Tc may be one of the players involved in the progression of liver cirrhosis to HCC.

2 July 2023 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
Reham HammadReham Hammad
Reham Hammad
MWMaisa A Abdel Wahab
Maisa A Abdel Wahab
NANehal Farouk Abdelsattar
Nehal Farouk Abdelsattar
MZMohamed Yahia Zakaria
Mohamed Yahia Zakaria
MEMona A Eldosoky
Mona A Eldosoky
RERasha Abd Elaziz Abd Elghany
Rasha Abd Elaziz Abd Elghany
Aims/Introduction: Peripheral artery disease (PAD) serves as a risk factor for diabetic foot ulcers (DFUs). PAD pathology involves atherosclerosis and impaired immunity. Non‐classical monocytes are believed to have an anti‐inflammatory role. 1,25‐Dihydroxy vitamin D (vitamin D3) is claimed to have immune‐modulating and lipid‐regulating roles. Vitamin D receptor is expressed on monocytes. We aimed to investigate if circulating non‐classical monocytes and vitamin D3 were implicated in DFUs associated with PAD.Materials and Methods: There were two groups of DFU patients: group 1 (n = 40) included patients with first‐degree DFUs not associated with PAD, and group 2 (n = 50) included patients with DFU with PAD. The monocyte phenotypes were detected using flow cytometry. Vitamin D3 was assessed by enzyme‐linked immunosorbent assay.Results: DFU patients with PAD showed a significant reduction in the frequency of non‐classical monocytes and vitamin D3 levels, when compared with DFU patients without PAD. The percentage of non‐classical monocytes positively correlated with vitamin D3 level (r = 0.4, P < 0.01) and high‐density lipoprotein (r = 0.5, P < 0.001), whereas it was negatively correlated with cholesterol (r = −0.5, P < 0.001). Vitamin D3 was negatively correlated with triglyceride/high‐density lipoprotein (r = −0.4, P < 0.01). Regression analysis showed that a high vitamin D3 serum level was a protective factor against PAD occurrence.Conclusions: Non‐classical monocytes frequency and vitamin D3 levels were significantly reduced in DFU patients with PAD. Non‐classical monocytes frequency was associated with vitamin D3 in DFUs patients, and both parameters were linked to lipid profile. Vitamin D3 upregulation was a risk‐reducing factor for PAD occurrence.

1 July 2021 in The Egyptian Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
HEHend M. El-Menyawy
Hend M. El-Menyawy
KMKarima M. Metwally
Karima M. Metwally
IAIbrahim R. Aly
Ibrahim R. Aly
AEAsmaa A. Abo Elqasem
Asmaa A. Abo Elqasem
AYAlaa A. Youssef
Alaa A. Youssef
Background: Schistosoma mansoni is a trematode helminth responsible for liver fibrosis or cirrhosis. Aim of the work: In the present work natural products Thymoquinone loaded with chitosan nanoparticle (TQ/ChNP)) (TQ/ChNP) were used to determine their therapeutic effect on S. mansoni infection. Materials and methods: A total of 40 healthy Swiss albino mice, 20-25 g in weight, procured from Theodor Bilharz Research Institute (TBRI) Imbaba, Egypt's Schistosome Biological Supply Center (SBSC). Results: The infected mice treated with TQ/ChNP showed a significant decrease in the total worm burden. Treatment with TQ/ChNP had a highly significant effect on mature worm burden, TQ/ChNP in prophylactic and therapeutic doses significantly increased the mean number of dead ova in comparison to control. TQ/ChNP had a high decrease effect on ova count in intestinal tissue and a moderate reduction on ova count in hepatic tissue. Prophylactic dose gave a high reduction effect on ova count in intestinal tissue. As regards the size of hepatic granuloma, TQ/ChNP had the highest significant reduction on mean granuloma diameter with noticeable improvement of hepatic pathology. TQ/ChNP treated group showed observable improvement of liver pathology with mild degeneration and slight-sized fibrocellular. Conclusion: Based on the outcome of this study, TQ/ChNP proved to have potential bioactivity against S. mansoni adult stages and its potentiality in improving hepatic pathology. Efficacy of TQ/ChNP to postpone progression in chronic liver diseases must be considered as preventive medicine in patients with hepatic disorders.

17 August 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
Reham HammadReham Hammad
Reham Hammad
RAReda Aglan
Reda Aglan
SMShaymaa A. Mohammed
Shaymaa A. Mohammed
EAEman Abu-Elnasr Awad
Eman Abu-Elnasr Awad
MEMarwa A. Elsaid
Marwa A. Elsaid
Nadia M HamdyNadia M Hamdy
Nadia M Hamdy
Background and Aim. Since virus-related hepatocellular carcinoma (HCC) pathogenesis involves liver inflammation, therefore, post-hepatitis C virus (HCV) infection would be a cause for liver cirrhosis that would progress to HCC. Cytotoxic T cells (Tc) are known to be involved in post-HCV complications and HCC pathogenesis. The inhibitory checkpoint Leukocyte-Associated Immunoglobulin-like Receptor-1 (LAIR-1) is expressed on Tc. Therefore, we aimed to determine whether the Tc expression level of LAIR-1 is associated with HCC progression post-HCV and moreover, to evaluate LAIR-1 expression as a non-invasive biomarker for HCC progression in the context of liver cirrhosis post-HCV genotype 4 (G4) in Egyptian patients’ peripheral venous blood liquid biopsy. We studied LAIR-1 expression on Tc related to the progression of liver cirrhosis in a case-controlled study enrolled 64 patients with post-HCV G4-HCC and 37 patients with post-HCV G4-liver cirrhosis. Methods: LAIR-1 expression was analyzed by flow cytometry. Results: LAIR-1 expression on Tc and the percentage of Tc positive for LAIR-1 (LAIR-1+Tc %) were significantly higher in the post-HCV G4-HCC group compared to the post-HCV G4-liver cirrhosis

1 April 2021 in The Egyptian Journal of Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
AEAsmaa A. Abo Elqasem
Asmaa A. Abo Elqasem
AMAly Mohamed
Aly Mohamed
Background: Vaccination is a very effective method of stimulating the immune response against infections. Adjuvants are employed to enhance the immune response, but they must be safe, inexpensive, and easy to use. Objective: This study aimed to evaluate gold nanoparticles as immune enhancers for rift valley fever vaccine. Methods: The rats were divided into four groups (10 each): the negative control group, rats immunized with nonadjuvanted rift valley fever vaccine and the last two rat groups immunized with rift valley fever vaccine combined with 40 μM of spherical gold nanoparticles and combined with 40 μM of rod-shaped gold nanoparticles, respectively. Results: Compared with rats receiving no treatment and rats treated with nonadjuvanted vaccine, rats treated with vaccines combined with gold nanoparticles exhibited toxic biochemical, histological and immunohistochemical changes, as shown by significant elevations in liver enzymatic markers and total bilirubin. The magnitude of the biochemical changes was dependent on the shape of the gold nanoparticles: the elevations in liver enzymatic markers and total bilirubin were greater in the group treated with spherical gold nanoparticles than in the group treated with rod-shaped gold nanoparticles. Conclusion: It can be concluded that gold nanoparticles are promising vaccine cellular and humoral immune enhancers/adjuvants via different cytokine pathways.

20 June 2025 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
AMAlya Mashaal
Alya Mashaal
BEBasma M Abou El-Nour
Basma M Abou El-Nour
FIFatma M Ismail
Fatma M Ismail
EEEman A Elewa
Eman A Elewa
EEEman A Elnoby
Eman A Elnoby
AEAsmaa A. Abo Elqasem
Asmaa A. Abo Elqasem
In pursuit of sustainable biocontrol strategies, this study explores Illicium verum (star anise) as a dual-action anti-inflammatory/oxidative and molluscicidal agent using Biomphalaria alexandrina, the intermediate host of Schistosoma mansoni, as an eco-relevant in vivo model. Two experimental snail groups were employed: a control group and a treatment group exposed to a sublethal concentration of I. verum extract (LC₁₀ = 315 ppm). Through a combined pipeline of phytochemical profiling, computational simulations, and in vivo assays, we identified flavonoids and phenylpropanoids with potent bioactivity. Molecular docking and ADMET screening highlighted kaempferol, quercetin, and rutin as top ligands, which bind effectively to key snail proteins such as cytochrome c oxidase and actin. In vivo analyses confirmed immunomodulatory effects, and these findings were validated through oxidative/inflammatory biomarker assays, which revealed altered cytokine levels (IFN-γ, IL-2 and IL-6), tissue remodeling, and reduced oxidative stress. Histopathological and immunohistochemical evaluations revealed significant tissue alterations in the digestive gland and head-foot regions of treated snails. Gene and protein interaction networks supported these findings by linking compound action to immune and oxidative regulatory pathways. This integrative study demonstrated that Illicium verum contains bioactive compounds capable of modulating oxidative stress, immune responses, and tissue integrity in B. alexandrina as an animal model. Integrating phytochemical analysis with in silico and molecular simulations offers a powerful approach for understanding and optimizing bioactive compounds. While phytochemical profiling identifies key constituents such as flavonoids and phenylpropanoids, computational tools predict their binding to biological targets, pharmacokinetics, and safety. This combination not only streamlines the discovery of effective and low-toxicity compounds but also clarifies their mechanisms of action at the molecular level, enhancing both the precision and efficiency of experimental validation. These results position star anise as a promising, eco-friendly candidate for the development of novel molluscicidal and anti-inflammatory agents supporting sustainable disease control strategies. Graphical Abstract